{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:36:50Z","timestamp":1791859010679,"version":"4.3.4"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Science and Higher Education, Poland","award":["DWD\/6\/0306\/2022"],"award-info":[{"award-number":["DWD\/6\/0306\/2022"]}]},{"name":"National Science Center, Poland","award":["020\/37\/K\/NZ3\/02783"],"award-info":[{"award-number":["020\/37\/K\/NZ3\/02783"]}]},{"name":"National Science Center, Poland","award":["020\/37\/K\/NZ3\/02783"],"award-info":[{"award-number":["020\/37\/K\/NZ3\/02783"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The hypothalamic\u2013pituitary\u2013adrenal (HPA) axis plays a central role in governing stress-related disorders such as major depressive disorder\u00a0(MDD), anxiety, and post-traumatic stress disorder. Chronic stress or early life trauma, known risk factors of disease, alter HPA axis activity and pattern of glucocorticoid\u00a0(GC) secretion. These changes have consequences for physiological processes controlled by glucocorticoid receptor (GR) signaling, such as immune response and metabolism. In the brain, the aberrant GR signaling translates to altered behavior, making the\u00a0GR pathway a viable target for therapies of stress-related disorders. One of the crucial elements of the pathway is FKBP5, a regulator of GR sensitivity and feedback control within the HPA axis,\u00a0in which genetic variants were shown to moderate the risk of developing psychiatric conditions. The difficulty in targeting\u00a0the GR-FKBP5 pathway stems from tailoring the intervention to specific brain regions and cell types, in the context of personalized genetic variations in GR and GR-associated genes, like\n                    <jats:italic>FKBP<\/jats:italic>\n                    5. The development of selective inhibitors, antagonists, and approaches based on targeted protein degradation offer insights into mechanistic aspects of disease and pave the way for improved therapy. These strategies can be employed either independently or in conjunction with conventional medications. Concomitant advancements in personalized drug screening (e.g. in vitro models exploiting induced pluripotent stem cells, iPSCs) bring the potential for optimization of therapy aiming to rescue central deficits originating from the HPA imbalance. In this mini-review, we discuss potential therapeutic strategies targeting GR signaling in stress-related disorders, with a focus on personalized approaches and advancements in drug development.\n                  <\/jats:p>","DOI":"10.1007\/s43440-024-00654-w","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T07:01:57Z","timestamp":1727938917000},"page":"1333-1345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Targeting glucocorticoid receptor signaling pathway for treatment of stress-related brain disorders"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6130-6391","authenticated-orcid":false,"given":"Tansu","family":"G\u00f6ver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2224-3989","authenticated-orcid":false,"given":"Michal","family":"Slezak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"654_CR1","doi-asserted-by":"publisher","DOI":"10.1159\/000362736","author":"NC Nicolaides","year":"2014","unstructured":"Nicolaides NC, Kyratzi E, Lamprokostopoulou A, Chrousos GP, Charmandari E. Stress, the stress system and the role of glucocorticoids. NeuroImmunoModulation. 2014. https:\/\/doi.org\/10.1159\/000362736.","journal-title":"NeuroImmunoModulation"},{"key":"654_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.11.071","author":"BS McEwen","year":"2008","unstructured":"McEwen BS. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol. 2008. https:\/\/doi.org\/10.1016\/j.ejphar.2007.11.071.","journal-title":"Eur J Pharmacol"},{"key":"654_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2013.09.017","author":"C Finsterwald","year":"2014","unstructured":"Finsterwald C, Alberini CM. Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies. Neurobiol Learn Mem. 2014. https:\/\/doi.org\/10.1016\/j.nlm.2013.09.017.","journal-title":"Neurobiol Learn Mem"},{"key":"654_CR4","doi-asserted-by":"publisher","DOI":"10.1210\/rp.59.1.333","author":"EFC van Rossum","year":"2004","unstructured":"van Rossum EFC, Lamberts SWJ. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res. 2004. https:\/\/doi.org\/10.1210\/rp.59.1.333.","journal-title":"Recent Prog Horm Res"},{"key":"654_CR5","doi-asserted-by":"publisher","DOI":"10.1210\/en.2014-1048","author":"ER De Kloet","year":"2014","unstructured":"De Kloet ER. From receptor balance to rational glucocorticoid therapy. Endocrinology. 2014. https:\/\/doi.org\/10.1210\/en.2014-1048.","journal-title":"Endocrinology"},{"key":"654_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.09.007","author":"RH Oakley","year":"2013","unstructured":"Oakley RH, Cidlowski JA. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol. 2013. https:\/\/doi.org\/10.1016\/j.jaci.2013.09.007.","journal-title":"J Allergy Clin Immunol"},{"key":"654_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30010024","author":"IB Mitre-Aguilar","year":"2023","unstructured":"Mitre-Aguilar IB, Moreno-Mitre D, Melendez-Zajgla J, Maldonado V, Jacobo-Herrera NJ, Ramirez-Gonzalez V, et al. The role of glucocorticoids in breast cancer therapy. Curr Oncol. 2023. https:\/\/doi.org\/10.3390\/curroncol30010024.","journal-title":"Curr Oncol"},{"key":"654_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2006.08.009","author":"TWW Pace","year":"2007","unstructured":"Pace TWW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun. 2007. https:\/\/doi.org\/10.1016\/j.bbi.2006.08.009.","journal-title":"Brain Behav Immun"},{"key":"654_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1152\/physrev.00041.2006","volume":"87","author":"BS McEwen","year":"2007","unstructured":"McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007;87:873\u2013904. https:\/\/doi.org\/10.1152\/physrev.00041.2006.","journal-title":"Physiol Rev"},{"key":"654_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1683","author":"ER De Kloet","year":"2005","unstructured":"De Kloet ER, Jo\u00ebls M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005. https:\/\/doi.org\/10.1038\/nrn1683.","journal-title":"Nat Rev Neurosci"},{"key":"654_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2013.07.003","author":"M Kadmiel","year":"2013","unstructured":"Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in health and disease. Trends Pharmacol Sci. 2013. https:\/\/doi.org\/10.1016\/j.tips.2013.07.003.","journal-title":"Trends Pharmacol Sci"},{"key":"654_CR12","doi-asserted-by":"publisher","DOI":"10.1210\/er.2015-1080","author":"H Oster","year":"2017","unstructured":"Oster H, Challet E, Ott V, Arvat E, de Kloet ER, Dijk DJ, et al. The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids. Endocr Rev. 2017. https:\/\/doi.org\/10.1210\/er.2015-1080.","journal-title":"Endocr Rev"},{"key":"654_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2018.03.003","author":"BP Flynn","year":"2018","unstructured":"Flynn BP, Conway-Campbell BL, Lightman SL. The emerging importance of ultradian glucocorticoid rhythms within metabolic pathology. Ann Endocrinol (Paris). 2018. https:\/\/doi.org\/10.1016\/j.ando.2018.03.003.","journal-title":"Ann Endocrinol (Paris)"},{"key":"654_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.coemr.2022.100352","author":"ER de Kloet","year":"2022","unstructured":"de Kloet ER. Brain mineralocorticoid and glucocorticoid receptor balance in neuroendocrine regulation and stress-related psychiatric etiopathologies. Curr Opin Endocr Metab Res. 2022. https:\/\/doi.org\/10.1016\/j.coemr.2022.100352.","journal-title":"Curr Opin Endocr Metab Res"},{"key":"654_CR15","doi-asserted-by":"publisher","unstructured":"Koning ASCAM, Buurstede JC, Van Weert LTCM, Meijer OC. Glucocorticoid and mineralocorticoid receptors in the brain: a transcriptional perspective. J Endocr Soc. 2019. https:\/\/doi.org\/10.1210\/js.2019-00158.","DOI":"10.1210\/js.2019-00158"},{"key":"654_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/mmbr.00064-15","author":"I Petta","year":"2016","unstructured":"Petta I, Dejager L, Ballegeer M, Lievens S, Tavernier J, De Bosscher K, et al. The interactome of the glucocorticoid receptor and its influence on the actions of glucocorticoids in combatting inflammatory and infectious diseases. Microbiol Mol Biol Rev. 2016. https:\/\/doi.org\/10.1128\/mmbr.00064-15.","journal-title":"Microbiol Mol Biol Rev"},{"key":"654_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep03539","author":"D Sinclair","year":"2013","unstructured":"Sinclair D, Fillman SG, Webster MJ, Weickert CS. Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness. Sci Rep. 2013. https:\/\/doi.org\/10.1038\/srep03539.","journal-title":"Sci Rep"},{"key":"654_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/CELLDISC.2016.2","author":"IO Ebong","year":"2016","unstructured":"Ebong IO, Beilsten-Edmands V, Patel NA, Morgner N, Robinson CV. The interchange of immunophilins leads to parallel pathways and different intermediates in the assembly of Hsp90 glucocorticoid receptor complexes. Cell Discov. 2016. https:\/\/doi.org\/10.1038\/CELLDISC.2016.2.","journal-title":"Cell Discov"},{"key":"654_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2011.08.001","author":"CL Storer","year":"2011","unstructured":"Storer CL, Dickey CA, Galigniana MD, Rein T, Cox MB. FKBP51 and FKBP52 in signaling and disease. Trends Endocrinol Metab. 2011. https:\/\/doi.org\/10.1016\/j.tem.2011.08.001.","journal-title":"Trends Endocrinol Metab"},{"key":"654_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1164265","author":"SH Meijsing","year":"2009","unstructured":"Meijsing SH, Pufall MA, So AY, Bates DL, Chen L, Yamamoto KR. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science (1979). 2009. https:\/\/doi.org\/10.1126\/science.1164265.","journal-title":"Science (1979)"},{"key":"654_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.03.027","author":"M Surjit","year":"2011","unstructured":"Surjit M, Ganti KP, Mukherji A, Ye T, Hua G, Metzger D, et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell. 2011. https:\/\/doi.org\/10.1016\/j.cell.2011.03.027.","journal-title":"Cell"},{"key":"654_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1522826113","author":"G Hua","year":"2016","unstructured":"Hua G, Ganti KP, Chambon P. Glucocorticoid-induced tethered transrepression requires SUMOylation of GR and formation of a SUMO-SMRT\/NCoR1-HDAC3 repressing complex. Proc Natl Acad Sci USA. 2016. https:\/\/doi.org\/10.1073\/pnas.1522826113.","journal-title":"Proc Natl Acad Sci USA"},{"key":"654_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2012.12.014","author":"D Ratman","year":"2013","unstructured":"Ratman D, Vanden Berghe W, Dejager L, Libert C, Tavernier J, Beck IM, et al. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering. Mol Cell Endocrinol. 2013. https:\/\/doi.org\/10.1016\/j.mce.2012.12.014.","journal-title":"Mol Cell Endocrinol"},{"key":"654_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.152","author":"ER Weikum","year":"2017","unstructured":"Weikum ER, Knuesel MT, Ortlund EA, Yamamoto KR. Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat Rev Mol Cell Biol. 2017. https:\/\/doi.org\/10.1038\/nrm.2016.152.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"654_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100687","author":"AN Gerber","year":"2021","unstructured":"Gerber AN, Newton R, Sasse SK. Repression of transcription by the glucocorticoid receptor: a parsimonious model for the genomics. J Biol Chem. 2021. https:\/\/doi.org\/10.1016\/j.jbc.2021.100687.","journal-title":"J Biol Chem"},{"key":"654_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01044-x","author":"AS H\u00e4usl","year":"2021","unstructured":"H\u00e4usl AS, Brix LM, Hartmann J, P\u00f6hlmann ML, Lopez JP, Menegaz D, et al. The co-chaperone Fkbp5 shapes the acute stress response in the paraventricular nucleus of the hypothalamus of male mice. Mol Psychiatry. 2021. https:\/\/doi.org\/10.1038\/s41380-021-01044-x.","journal-title":"Mol Psychiatry"},{"key":"654_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.235","author":"AS Zannas","year":"2016","unstructured":"Zannas AS, Wiechmann T, Gassen NC, Binder EB. Gene-stress-epigenetic regulation of FKBP5: clinical and translational implications. Neuropsychopharmacology. 2016. https:\/\/doi.org\/10.1038\/npp.2015.235.","journal-title":"Neuropsychopharmacology"},{"key":"654_CR28","doi-asserted-by":"publisher","DOI":"10.2174\/187152731131200121","author":"JC O\u2019Leary","year":"2013","unstructured":"O\u2019Leary JC, Zhang B, Koren J, Blair L, Dickey CA. The role of FKBP5 in mood disorders: action of FKBP5 on steroid hormone receptors leads to questions about its evolutionary importance. CNS Neurol Disord Drug Targets. 2013. https:\/\/doi.org\/10.2174\/187152731131200121.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"654_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/biosci\/biaa114","author":"C Zimmer","year":"2020","unstructured":"Zimmer C, Hanson HE, Wildman DE, Uddin M, Martin LB. FKBP5: a key mediator of how vertebrates flexibly cope with adversity. Bioscience. 2020. https:\/\/doi.org\/10.1093\/biosci\/biaa114.","journal-title":"Bioscience"},{"key":"654_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.97","author":"JD Gray","year":"2017","unstructured":"Gray JD, Kogan JF, Marrocco J, McEwen BS. Genomic and epigenomic mechanisms of glucocorticoids in the brain. Nat Rev Endocrinol. 2017. https:\/\/doi.org\/10.1038\/nrendo.2017.97.","journal-title":"Nat Rev Endocrinol"},{"key":"654_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.266","author":"JW Smoller","year":"2016","unstructured":"Smoller JW. The genetics of stress-related disorders: PTSD, depression, and anxiety disorders. Neuropsychopharmacology. 2016. https:\/\/doi.org\/10.1038\/npp.2015.266.","journal-title":"Neuropsychopharmacology"},{"key":"654_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00159-7","author":"F Holsboer","year":"2000","unstructured":"Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000. https:\/\/doi.org\/10.1016\/S0893-133X(00)00159-7.","journal-title":"Neuropsychopharmacology"},{"key":"654_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2013.12.004","author":"M Belvederi Murri","year":"2014","unstructured":"Belvederi Murri M, Pariante C, Mondelli V, Masotti M, Atti AR, Mellacqua Z, et al. HPA axis and aging in depression: systematic review and meta-analysis. Psychoneuroendocrinology. 2014. https:\/\/doi.org\/10.1016\/j.psyneuen.2013.12.004.","journal-title":"Psychoneuroendocrinology"},{"key":"654_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2008.06.006","author":"CM Pariante","year":"2008","unstructured":"Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008. https:\/\/doi.org\/10.1016\/j.tins.2008.06.006.","journal-title":"Trends Neurosci"},{"key":"654_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2015.05.034","author":"J Arloth","year":"2015","unstructured":"Arloth J, Bogdan R, Weber P, Frishman G, Menke A, Wagner KV, et al. Genetic differences in the immediate transcriptome response to stress predict risk-related brain function and psychiatric disorders. Neuron. 2015. https:\/\/doi.org\/10.1016\/j.neuron.2015.05.034.","journal-title":"Neuron"},{"key":"654_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2002690","author":"T Carrillo-Roa","year":"2017","unstructured":"Carrillo-Roa T, Labermaier C, Weber P, Herzog DP, Lareau C, Santarelli S, et al. Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity. PLoS Biol. 2017. https:\/\/doi.org\/10.1371\/journal.pbio.2002690.","journal-title":"PLoS Biol"},{"key":"654_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ng1479","author":"EB Binder","year":"2004","unstructured":"Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, P\u00fctz B, et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet. 2004. https:\/\/doi.org\/10.1038\/ng1479.","journal-title":"Nat Genet"},{"key":"654_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1182345","author":"M Malekpour","year":"2023","unstructured":"Malekpour M, Shekouh D, Safavinia ME, Shiralipour S, Jalouli M, Mortezanejad S, et al. Role of FKBP5 and its genetic mutations in stress-induced psychiatric disorders: an opportunity for drug discovery. Front Psychiatry. 2023. https:\/\/doi.org\/10.3389\/fpsyt.2023.1182345.","journal-title":"Front Psychiatry"},{"key":"654_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01549-z","author":"V Nold","year":"2022","unstructured":"Nold V, Portenhauser M, Del Prete D, Blasius A, Harris I, Koros E, et al. Impact of Fkbp5 \u00d7 early life adversity \u00d7 sex in humanised mice on multidimensional stress responses and circadian rhythmicity. Mol Psychiatry. 2022. https:\/\/doi.org\/10.1038\/s41380-022-01549-z.","journal-title":"Mol Psychiatry"},{"key":"654_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9123792","author":"B Misiak","year":"2020","unstructured":"Misiak B, Karpi\u0144ski P, Szmida E, Gra\u017alewski T, Jab\u0142o\u0144ski M, Cyranka K, et al. Adverse childhood experiences and methylation of the fkbp5 gene in patients with psychotic disorders. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9123792.","journal-title":"J Clin Med"},{"key":"654_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3275","author":"T Klengel","year":"2013","unstructured":"Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci. 2013. https:\/\/doi.org\/10.1038\/nn.3275.","journal-title":"Nat Neurosci"},{"key":"654_CR42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1816847116","author":"AS Zannas","year":"2019","unstructured":"Zannas AS, Jia M, Hafner K, Baumert J, Wiechmann T, Pape JC, et al. Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-\u03baB-driven inflammation and cardiovascular risk. Proc Natl Acad Sci USA. 2019. https:\/\/doi.org\/10.1073\/pnas.1816847116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"654_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2024.03.003","author":"TL Kremer","year":"2024","unstructured":"Kremer TL, Chen J, Buhl A, Berhe O, Bilek E, Geiger LS, et al. Multimodal associations of FKBP5 methylation with emotion-regulatory brain circuits. Biol Psychiatry. 2024. https:\/\/doi.org\/10.1016\/j.biopsych.2024.03.003.","journal-title":"Biol Psychiatry"},{"key":"654_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01762-w","author":"IA von M\u00fccke-Heim","year":"2023","unstructured":"von M\u00fccke-Heim IA, Urbina-Trevi\u00f1o L, Bordes J, Ries C, Schmidt MV, Deussing JM. Introducing a depression-like syndrome for translational neuropsychiatry: a plea for taxonomical validity and improved comparability between humans and mice. Mol Psychiatry. 2023. https:\/\/doi.org\/10.1038\/s41380-022-01762-w.","journal-title":"Mol Psychiatry"},{"key":"654_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cells12232726","author":"E Knezevic","year":"2023","unstructured":"Knezevic E, Nenic K, Milanovic V, Knezevic NN. The role of cortisol in chronic stress, neurodegenerative diseases, and psychological disorders. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12232726.","journal-title":"Cells"},{"key":"654_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.coemr.2022.100356","author":"N Amasi-Hartoonian","year":"2022","unstructured":"Amasi-Hartoonian N, Sforzini L, Cattaneo A, Pariante CM. Cause or consequence? Understanding the role of cortisol in the increased inflammation observed in depression. Curr Opin Endocr Metab Res. 2022. https:\/\/doi.org\/10.1016\/j.coemr.2022.100356.","journal-title":"Curr Opin Endocr Metab Res"},{"key":"654_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.01.080","author":"H Hori","year":"2024","unstructured":"Hori H, Yoshida F, Ishida I, Matsuo J, Ogawa S, Hattori K, et al. Blood mRNA expression levels of glucocorticoid receptors and FKBP5 are associated with depressive disorder and altered HPA axis. J Affect Disord. 2024. https:\/\/doi.org\/10.1016\/j.jad.2024.01.080.","journal-title":"J Affect Disord"},{"key":"654_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01738-y","author":"L Cui","year":"2024","unstructured":"Cui L, Li S, Wang S, Wu X, Liu Y, Yu W, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024. https:\/\/doi.org\/10.1038\/s41392-024-01738-y.","journal-title":"Signal Transduct Target Ther"},{"key":"654_CR49","unstructured":"Lin TY, Hanna J, Ishak WW. Psychiatric symptoms in cushing\u2019s syndrome: a systematic review. Innov Clin Neurosci. 2020."},{"key":"654_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091018","author":"S Berger","year":"2019","unstructured":"Berger S, Gureczny S, Reisinger SN, Horvath O, Pollak DD. Effect of chronic corticosterone treatment on depression-like behavior and sociability in female and male c57bl\/6n mice. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8091018.","journal-title":"Cells"},{"key":"654_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2018.09.059","author":"H Ding","year":"2018","unstructured":"Ding H, Cui XY, Cui SY, Ye H, Hu X, Zhao HL, et al. Depression-like behaviors induced by chronic corticosterone exposure via drinking water: time-course analysis. Neurosci Lett. 2018. https:\/\/doi.org\/10.1016\/j.neulet.2018.09.059.","journal-title":"Neurosci Lett"},{"key":"654_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat8078","author":"RN Moda-Sava","year":"2019","unstructured":"Moda-Sava RN, Murdock MH, Parekh PK, Fetcho RN, Huang BS, Huynh TN, et al. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science (1979). 2019. https:\/\/doi.org\/10.1126\/science.aat8078.","journal-title":"Science (1979)"},{"key":"654_CR53","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.18070881","author":"R Border","year":"2019","unstructured":"Border R, Johnson EC, Evans LM, Smolen A, Berley N, Sullivan PF, et al. No support for historical candidate gene or candidate gene-by-interaction hypotheses for major depression across multiple large samples. Am J Psychiatry. 2019. https:\/\/doi.org\/10.1176\/appi.ajp.2018.18070881.","journal-title":"Am J Psychiatry"},{"key":"654_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01003-y","author":"CH Huang","year":"2024","unstructured":"Huang CH, Yang TT, Lin KI. Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells. J Biomed Sci. 2024. https:\/\/doi.org\/10.1186\/s12929-024-01003-y.","journal-title":"J Biomed Sci"},{"key":"654_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2013.10.020","author":"MF Juruena","year":"2014","unstructured":"Juruena MF. Early-life stress and HPA axis trigger recurrent adulthood depression. Epilepsy Behav. 2014. https:\/\/doi.org\/10.1016\/j.yebeh.2013.10.020.","journal-title":"Epilepsy Behav"},{"key":"654_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001139","author":"MJ Webster","year":"2002","unstructured":"Webster MJ, Knable MB, O\u2019Grady J, Orthmann J, Weickert CS. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry. 2002. https:\/\/doi.org\/10.1038\/sj.mp.4001139.","journal-title":"Mol Psychiatry"},{"key":"654_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02345-1","author":"HS Rizavi","year":"2023","unstructured":"Rizavi HS, Khan OS, Zhang H, Bhaumik R, Grayson DR, Pandey GN. Methylation and expression of glucocorticoid receptor exon-1 variants and FKBP5 in teenage suicide-completers. Transl Psychiatry. 2023. https:\/\/doi.org\/10.1038\/s41398-023-02345-1.","journal-title":"Transl Psychiatry"},{"key":"654_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.09.052","author":"MF Juruena","year":"2018","unstructured":"Juruena MF, Bocharova M, Agustini B, Young AH. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review. J Affect Disord. 2018. https:\/\/doi.org\/10.1016\/j.jad.2017.09.052.","journal-title":"J Affect Disord"},{"key":"654_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.225","author":"G Guidotti","year":"2013","unstructured":"Guidotti G, Calabrese F, Anacker C, Racagni G, Pariante CM, Riva MA. Glucocorticoid receptor and fkbp5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology. 2013. https:\/\/doi.org\/10.1038\/npp.2012.225.","journal-title":"Neuropsychopharmacology"},{"key":"654_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.35","author":"MG Arnett","year":"2015","unstructured":"Arnett MG, Pan MS, Doak W, Cyr PEP, Muglia LM, Muglia LJ. The role of glucocorticoid receptor-dependent activity in the amygdala central nucleus and reversibility of early-life stress programmed behavior. Transl Psychiatry. 2015. https:\/\/doi.org\/10.1038\/tp.2015.35.","journal-title":"Transl Psychiatry"},{"key":"654_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2016.44","author":"M Antunica-Noguerol","year":"2016","unstructured":"Antunica-Noguerol M, Budzi\u00f1ski ML, Druker J, Gassen NC, Sokn MC, Senin S, et al. The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51. Cell Death Differ. 2016. https:\/\/doi.org\/10.1038\/cdd.2016.44.","journal-title":"Cell Death Differ"},{"key":"654_CR62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1524215113","author":"CK Tan","year":"2016","unstructured":"Tan CK, Wahli W. A trilogy of glucocorticoid receptor actions. Proc Natl Acad Sci USA. 2016. https:\/\/doi.org\/10.1073\/pnas.1524215113.","journal-title":"Proc Natl Acad Sci USA"},{"key":"654_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-021-00743-2","author":"DB Fraga","year":"2021","unstructured":"Fraga DB, Camargo A, Olescowicz G, Padilha DA, Mina F, Budni J, et al. Ketamine, but not fluoxetine, rapidly rescues corticosterone-induced impairments on glucocorticoid receptor and dendritic branching in the hippocampus of mice. Metab Brain Dis. 2021. https:\/\/doi.org\/10.1007\/s11011-021-00743-2.","journal-title":"Metab Brain Dis"},{"key":"654_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2012.00024","author":"JLW Yau","year":"2012","unstructured":"Yau JLW, Seckl JR. Local amplification of glucocorticoids in the aging brain and impaired spatial memory. Front Aging Neurosci. 2012. https:\/\/doi.org\/10.3389\/fnagi.2012.00024.","journal-title":"Front Aging Neurosci"},{"key":"654_CR65","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022308429992","author":"LK Nieman","year":"2002","unstructured":"Nieman LK. Medical therapy of Cushing\u2019s disease. Pituitary. 2002. https:\/\/doi.org\/10.1023\/A:1022308429992.","journal-title":"Pituitary"},{"key":"654_CR66","doi-asserted-by":"publisher","DOI":"10.1530\/eje-14-1014","author":"E Daniel","year":"2015","unstructured":"Daniel E, Newell-Price JDC. Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing\u2019s syndrome. Eur J Endocrinol. 2015. https:\/\/doi.org\/10.1530\/eje-14-1014.","journal-title":"Eur J Endocrinol"},{"key":"654_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2013.05.031","author":"MY Vincent","year":"2013","unstructured":"Vincent MY, Hussain RJ, Zampi ME, Sheeran K, Solomon MB, Herman JP, et al. Sensitivity of depression-like behavior to glucocorticoids and antidepressants is independent of forebrain glucocorticoid receptors. Brain Res. 2013. https:\/\/doi.org\/10.1016\/j.brainres.2013.05.031.","journal-title":"Brain Res"},{"key":"654_CR68","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.12.1235","author":"H Jahn","year":"2004","unstructured":"Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch Gen Psychiatry. 2004. https:\/\/doi.org\/10.1001\/archpsyc.61.12.1235.","journal-title":"Arch Gen Psychiatry"},{"key":"654_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)00105-X","author":"H Cohen","year":"2000","unstructured":"Cohen H, Benjamin J, Kaplan Z, Kotler M. Administration of high-dose ketoconazole, an inhibitor of steroid synthesis, prevents posttraumatic anxiety in an animal model. Eur Neuropsychopharmacol. 2000. https:\/\/doi.org\/10.1016\/S0924-977X(00)00105-X.","journal-title":"Eur Neuropsychopharmacol"},{"key":"654_CR70","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa736","author":"R Agarwal","year":"2021","unstructured":"Agarwal R, Kolkhof P, Bakris G, Bauersachs J, Haller H, Wada T, et al. Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine. Eur Heart J. 2021. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa736.","journal-title":"Eur Heart J"},{"key":"654_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2012.09.011","author":"TC Wu","year":"2013","unstructured":"Wu TC, Chen HT, Chang HY, Yang CY, Hsiao MC, Cheng ML, et al. Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior. Psychoneuroendocrinology. 2013. https:\/\/doi.org\/10.1016\/j.psyneuen.2012.09.011.","journal-title":"Psychoneuroendocrinology"},{"key":"654_CR72","doi-asserted-by":"publisher","DOI":"10.1124\/pr.112.005892","author":"M Jo\u00ebls","year":"2012","unstructured":"Jo\u00ebls M, Angela Sarabdjitsingh R, Karst H. Unraveling the time domains of corticosteroid hormone influences on brain activity: Rapid, slow, and chronic modes. Pharmacol Rev. 2012. https:\/\/doi.org\/10.1124\/pr.112.005892.","journal-title":"Pharmacol Rev"},{"key":"654_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01899-0","author":"U Kintscher","year":"2023","unstructured":"Kintscher U, Edelmann F. The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction. Cardiovasc Diabetol. 2023. https:\/\/doi.org\/10.1186\/s12933-023-01899-0.","journal-title":"Cardiovasc Diabetol"},{"key":"654_CR74","unstructured":"Gallagher P, Young AH. Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications. Neuropsychiatr Dis Treat. 2006;2."},{"key":"654_CR75","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200110000-00009","author":"JK Belanoff","year":"2001","unstructured":"Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF. Rapid reversal of psychotic depression using mifepristone. J Clin Psychopharmacol. 2001. https:\/\/doi.org\/10.1097\/00004714-200110000-00009.","journal-title":"J Clin Psychopharmacol"},{"key":"654_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300884","author":"BH Flores","year":"2006","unstructured":"Flores BH, Kenna H, Keller J, Solvason HB, Schatzberg AF. Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology. 2006. https:\/\/doi.org\/10.1038\/sj.npp.1300884.","journal-title":"Neuropsychopharmacology"},{"key":"654_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)01088-X","author":"CM Pariante","year":"2001","unstructured":"Pariante CM, Miller AH. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry. 2001. https:\/\/doi.org\/10.1016\/S0006-3223(00)01088-X.","journal-title":"Biol Psychiatry"},{"key":"654_CR78","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-2793","author":"DC West","year":"2018","unstructured":"West DC, Kocherginsky M, Tonsing-Carter EY, Dolcen DN, Hosfield DJ, Lastra RR, et al. Discovery of a glucocorticoid receptor (gr) activity signature using selective gr antagonis in er-negative breast cancer. Clin Cancer Res. 2018. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-2793.","journal-title":"Clin Cancer Res"},{"key":"654_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.692574","author":"SM Qi","year":"2021","unstructured":"Qi SM, Dong J, Xu ZY, Cheng XD, Zhang WD, Qin JJ. PROTAC: an effective targeted protein degradation strategy for cancer therapy. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.692574.","journal-title":"Front Pharmacol"},{"key":"654_CR80","doi-asserted-by":"publisher","DOI":"10.1210\/me.2003-0189","author":"LN Song","year":"2004","unstructured":"Song LN, Coghlan M, Gelmann EP. Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor. Mol Endocrinol. 2004. https:\/\/doi.org\/10.1210\/me.2003-0189.","journal-title":"Mol Endocrinol"},{"key":"654_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115839","author":"J Song","year":"2023","unstructured":"Song J, Hu M, Zhou J, Xie S, Li T, Li Y. Targeted protein degradation in drug development: recent advances and future challenges. Eur J Med Chem. 2023. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115839.","journal-title":"Eur J Med Chem"},{"key":"654_CR82","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.141230798","author":"KM Sakamoto","year":"2001","unstructured":"Sakamoto KM, Kim KB, Kumagai A, Mercurio F, Crews CM, Deshaies RJ. Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc Natl Acad Sci USA. 2001. https:\/\/doi.org\/10.1073\/pnas.141230798.","journal-title":"Proc Natl Acad Sci USA"},{"key":"654_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2545-9","author":"SM Banik","year":"2020","unstructured":"Banik SM, Pedram K, Wisnovsky S, Ahn G, Riley NM, Bertozzi CR. Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature. 2020. https:\/\/doi.org\/10.1038\/s41586-020-2545-9.","journal-title":"Nature"},{"key":"654_CR84","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.0c10008","author":"AD Cotton","year":"2021","unstructured":"Cotton AD, Nguyen DP, Gramespacher JA, Seiple IB, Wells JA. Development of antibody-based PROTACs for the degradation of the cell-surface immune checkpoint protein PD-L1. J Am Chem Soc. 2021. https:\/\/doi.org\/10.1021\/jacs.0c10008.","journal-title":"J Am Chem Soc"},{"key":"654_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.033","author":"D Clift","year":"2017","unstructured":"Clift D, McEwan WA, Labzin LI, Konieczny V, Mogessie B, James LC, et al. A method for the acute and rapid degradation of endogenous proteins. Cell. 2017. https:\/\/doi.org\/10.1016\/j.cell.2017.10.033.","journal-title":"Cell"},{"key":"654_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddtec.2018.12.002","author":"M Naito","year":"2019","unstructured":"Naito M, Ohoka N, Shibata N. SNIPERs\u2014Hijacking IAP activity to induce protein degradation. Drug Discov Today Technol. 2019. https:\/\/doi.org\/10.1016\/j.ddtec.2018.12.002.","journal-title":"Drug Discov Today Technol"},{"key":"654_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.685106","author":"M He","year":"2021","unstructured":"He M, Lv W, Rao Y. Opportunities and challenges of small molecule induced targeted protein degradation. Front Cell Dev Biol. 2021. https:\/\/doi.org\/10.3389\/fcell.2021.685106.","journal-title":"Front Cell Dev Biol"},{"key":"654_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00966-4","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhao J, Zhong K, Tong A, Jia D. Targeted protein degradation: mechanisms, strategies and application. Signal Transduct Target Ther. 2022. https:\/\/doi.org\/10.1038\/s41392-022-00966-4.","journal-title":"Signal Transduct Target Ther"},{"key":"654_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103395","author":"N Guedeney","year":"2023","unstructured":"Guedeney N, Cornu M, Schwalen F, Kieffer C, Voisin-Chiret AS. PROTAC technology: a new drug design for chemical biology with many challenges in drug discovery. Drug Discov Today. 2023. https:\/\/doi.org\/10.1016\/j.drudis.2022.103395.","journal-title":"Drug Discov Today"},{"key":"654_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.211","author":"AC Lai","year":"2017","unstructured":"Lai AC, Crews CM. Induced protein degradation: an emerging drug discovery paradigm. Nat Rev Drug Discov. 2017. https:\/\/doi.org\/10.1038\/nrd.2016.211.","journal-title":"Nat Rev Drug Discov"},{"key":"654_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2015.05.009","author":"J Lu","year":"2015","unstructured":"Lu J, Qian Y, Altieri M, Dong H, Wang J, Raina K, et al. Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4. Chem Biol. 2015. https:\/\/doi.org\/10.1016\/j.chembiol.2015.05.009.","journal-title":"Chem Biol"},{"key":"654_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1858","author":"DP Bondeson","year":"2015","unstructured":"Bondeson DP, Mares A, Smith IED, Ko E, Campos S, Miah AH, et al. Catalytic in vivo protein knockdown by small-molecule PROTACs. Nat Chem Biol. 2015. https:\/\/doi.org\/10.1038\/nchembio.1858.","journal-title":"Nat Chem Biol"},{"key":"654_CR93","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab1433","author":"GE Winter","year":"2015","unstructured":"Winter GE, Buckley DL, Paulk J, Roberts JM, Souza A, Dhe-Paganon S, et al. Phthalimide conjugation as a strategy for in vivo target protein degradation. Science (1979). 2015. https:\/\/doi.org\/10.1126\/science.aab1433.","journal-title":"Science (1979)"},{"key":"654_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116166","author":"X Wang","year":"2024","unstructured":"Wang X, Qin ZL, Li N, Jia MQ, Liu QG, Bai YR, et al. Annual review of PROTAC degraders as anticancer agents in 2022. Eur J Med Chem. 2024. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116166.","journal-title":"Eur J Med Chem"},{"key":"654_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00371-6","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s M, Langley DR, Crews CM. PROTAC targeted protein degraders: the past is prologue. Nat Rev Drug Discov. 2022. https:\/\/doi.org\/10.1038\/s41573-021-00371-6.","journal-title":"Nat Rev Drug Discov"},{"key":"654_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44031-2","author":"M Gazorpak","year":"2023","unstructured":"Gazorpak M, Hugentobler KM, Paul D, Germain PL, Kretschmer M, Ivanova I, et al. Harnessing PROTAC technology to combat stress hormone receptor activation. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-023-44031-2.","journal-title":"Nat Commun"},{"key":"654_CR97","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-022-01262-8","author":"R Pivonello","year":"2022","unstructured":"Pivonello R, Simeoli C, Di Paola N, Colao A. Cushing\u2019s disease: adrenal steroidogenesis inhibitors. Pituitary. 2022. https:\/\/doi.org\/10.1007\/s11102-022-01262-8.","journal-title":"Pituitary"},{"key":"654_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/biom13081164","author":"BI Thomas","year":"2023","unstructured":"Thomas BI, Lewis HL, Jones DH, Ward SE. Central nervous system targeted protein degraders. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13081164.","journal-title":"Biomolecules"},{"key":"654_CR99","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.201483","author":"SL Lim","year":"2019","unstructured":"Lim SL, Damnernsawad A, Shyamsunder P, Chng WJ, Han BC, Xu L, et al. Proteolysis targeting chimeric molecules as therapy for multiple myeloma: efficacy, biomarker and drug combinations. Haematologica. 2019. https:\/\/doi.org\/10.3324\/haematol.2018.201483.","journal-title":"Haematologica"},{"key":"654_CR100","doi-asserted-by":"publisher","DOI":"10.3109\/01677060903567849","author":"JJ Higgins","year":"2010","unstructured":"Higgins JJ, Tal AL, Sun X, Hauck SCR, Hao J, Kosofosky BE, et al. Temporal and spatial mouse brain expression of cereblon, an ionic channel regulator involved in human intelligence. J Neurogenet. 2010. https:\/\/doi.org\/10.3109\/01677060903567849.","journal-title":"J Neurogenet"},{"key":"654_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2017.09.009","author":"GM Burslem","year":"2018","unstructured":"Burslem GM, Smith BE, Lai AC, Jaime-Figueroa S, McQuaid DC, Bondeson DP, et al. The advantages of targeted protein degradation over inhibition: an RTK case study. Cell Chem Biol. 2018. https:\/\/doi.org\/10.1016\/j.chembiol.2017.09.009.","journal-title":"Cell Chem Biol"},{"key":"654_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010974","author":"L Xie","year":"2023","unstructured":"Xie L, Xie L. Elucidation of genome-wide understudied proteins targeted by PROTAC-induced degradation using interpretable machine learning. PLoS Comput Biol. 2023. https:\/\/doi.org\/10.1371\/journal.pcbi.1010974.","journal-title":"PLoS Comput Biol"},{"key":"654_CR103","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.13l01578","author":"S Kundu","year":"2014","unstructured":"Kundu S, Bryk J, Alam A. Resolution of suicidal ideation with corticosteroids in a patient with concurrent addison\u2019s disease and depression. Prim Care Compan J Clin Psychiatry. 2014. https:\/\/doi.org\/10.4088\/PCC.13l01578.","journal-title":"Prim Care Compan J Clin Psychiatry"},{"key":"654_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/art.20583","author":"F Buttgereit","year":"2004","unstructured":"Buttgereit F, Straub RH, Wehling M, Burmester GR. Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action. Arthritis Rheumatol. 2004. https:\/\/doi.org\/10.1002\/art.20583.","journal-title":"Arthritis Rheumatol"},{"key":"654_CR105","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-023-01213-x","author":"D Morales Castro","year":"2023","unstructured":"Morales Castro D, Dresser L, Granton J, Fan E. Pharmacokinetic alterations associated with critical illness. Clin Pharmacokinet. 2023. https:\/\/doi.org\/10.1007\/s40262-023-01213-x.","journal-title":"Clin Pharmacokinet"},{"key":"654_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2019.02.004","author":"ML Scherholz","year":"2019","unstructured":"Scherholz ML, Schlesinger N, Androulakis IP. Chronopharmacology of glucocorticoids. Adv Drug Deliv Rev. 2019. https:\/\/doi.org\/10.1016\/j.addr.2019.02.004.","journal-title":"Adv Drug Deliv Rev"},{"key":"654_CR107","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.2.265","author":"GW Arana","year":"1995","unstructured":"Arana GW, Santos AB, Laraia MT, McLeod-Bryant S, Beale MD, Rames LJ, et al. Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial. Am J Psychiatry. 1995. https:\/\/doi.org\/10.1176\/ajp.152.2.265.","journal-title":"Am J Psychiatry"},{"key":"654_CR108","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1908264116","author":"G Hua","year":"2019","unstructured":"Hua G, Zein N, Paulen L, Chambon P. The glucocorticoid receptor agonistic modulators CpdX and CpdX-D3 do not generate the debilitating effects of synthetic glucocorticoids. Proc Natl Acad Sci USA. 2019. https:\/\/doi.org\/10.1073\/pnas.1908264116.","journal-title":"Proc Natl Acad Sci USA"},{"key":"654_CR109","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01690","author":"L Ripa","year":"2018","unstructured":"Ripa L, Edman K, Dearman M, Edenro G, Hendrickx R, Ullah V, et al. Discovery of a novel oral glucocorticoid receptor modulator (AZD9567) with improved side effect profile. J Med Chem. 2018. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01690.","journal-title":"J Med Chem"},{"key":"654_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.07.041","author":"J Hartmann","year":"2012","unstructured":"Hartmann J, Wagner KV, Liebl C, Scharf SH, Wang XD, Wolf M, et al. The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology. 2012. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.07.041.","journal-title":"Neuropharmacology"},{"key":"654_CR111","doi-asserted-by":"publisher","DOI":"10.1002\/epi4.12749","author":"AA Asadi-Pooya","year":"2023","unstructured":"Asadi-Pooya AA, Malekpour M, Zamiri B, Kashkooli M, Firouzabadi N. FKBP5 blockade may provide a new horizon for the treatment of stress-associated disorders: an in-silico study. Epilepsia Open. 2023. https:\/\/doi.org\/10.1002\/epi4.12749.","journal-title":"Epilepsia Open"},{"key":"654_CR112","doi-asserted-by":"publisher","unstructured":"Bonezi V, Genvigir FDV, Salgado PC, Felipe CR, Tedesco-Silva H Jr, Medina-Pestana JO, et al. Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy. Ann Transl Med. 2020. https:\/\/doi.org\/10.21037\/atm-20-1757.","DOI":"10.21037\/atm-20-1757"},{"key":"654_CR113","doi-asserted-by":"publisher","DOI":"10.1159\/000515048","author":"JM Nogueira","year":"2021","unstructured":"Nogueira JM, Freire MJ, Nova VV, Jesus G. When paranoia comes with the treatment: psychosis associated with tacrolimus use. Case Rep Nephrol Dial. 2021. https:\/\/doi.org\/10.1159\/000515048.","journal-title":"Case Rep Nephrol Dial"},{"key":"654_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaclp.2023.09.002","author":"M Gunther","year":"2023","unstructured":"Gunther M, Jiang S, Banga A, Sher Y. Delayed-onset psychosis secondary to tacrolimus neurotoxicity after lung transplant: a case report and systematic review. J Acad Consult Liaison Psychiatry. 2023. https:\/\/doi.org\/10.1016\/j.jaclp.2023.09.002.","journal-title":"J Acad Consult Liaison Psychiatry"},{"key":"654_CR115","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-019-00062-6","author":"YJ Shin","year":"2019","unstructured":"Shin YJ, Chun YT, Lim SW, Luo K, Quan Y, Cui S, et al. Influence of tacrolimus on depressive-like behavior in diabetic rats through brain-derived neurotrophic factor regulation in the hippocampus. Neurotox Res. 2019. https:\/\/doi.org\/10.1007\/s12640-019-00062-6.","journal-title":"Neurotox Res"},{"key":"654_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1699","author":"S Gaali","year":"2015","unstructured":"Gaali S, Kirschner A, Cuboni S, Hartmann J, Kozany C, Balsevich G, et al. Selective inhibitors of the FK506-binding protein 51 by induced fit. Nat Chem Biol. 2015. https:\/\/doi.org\/10.1038\/nchembio.1699.","journal-title":"Nat Chem Biol"},{"key":"654_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01425","author":"JM Kolos","year":"2018","unstructured":"Kolos JM, Voll AM, Bauder M, Hausch F. FKBP ligands\u2014where we are and where to go? Front Pharmacol. 2018. https:\/\/doi.org\/10.3389\/fphar.2018.01425.","journal-title":"Front Pharmacol"},{"key":"654_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4050","author":"RS Duman","year":"2016","unstructured":"Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016. https:\/\/doi.org\/10.1038\/nm.4050.","journal-title":"Nat Med"},{"key":"654_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01755-9","author":"MG Codagnone","year":"2022","unstructured":"Codagnone MG, Kara N, Ratsika A, Levone BR, van de Wouw M, Tan LA, et al. Inhibition of FKBP51 induces stress resilience and alters hippocampal neurogenesis. Mol Psychiatry. 2022. https:\/\/doi.org\/10.1038\/s41380-022-01755-9.","journal-title":"Mol Psychiatry"},{"key":"654_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2021.05.008","author":"E Castr\u00e9n","year":"2021","unstructured":"Castr\u00e9n E, Monteggia LM. Brain-derived neurotrophic factor signaling in depression and antidepressant action. Biol Psychiatry. 2021. https:\/\/doi.org\/10.1016\/j.biopsych.2021.05.008.","journal-title":"Biol Psychiatry"},{"key":"654_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24810-5","author":"S Martinelli","year":"2021","unstructured":"Martinelli S, Anderzhanova EA, Bajaj T, Wiechmann S, Dethloff F, Weckmann K, et al. Stress-primed secretory autophagy promotes extracellular BDNF maturation by enhancing MMP9 secretion. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/s41467-021-24810-5.","journal-title":"Nat Commun"},{"key":"654_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2009.05.021","author":"EB Binder","year":"2009","unstructured":"Binder EB. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology. 2009. https:\/\/doi.org\/10.1016\/j.psyneuen.2009.05.021.","journal-title":"Psychoneuroendocrinology"},{"key":"654_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2013.01.032","author":"R Sinha","year":"2013","unstructured":"Sinha R, Jastreboff AM. Stress as a common risk factor for obesity and addiction. Biol Psychiatry. 2013. https:\/\/doi.org\/10.1016\/j.biopsych.2013.01.032.","journal-title":"Biol Psychiatry"},{"key":"654_CR124","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12758","author":"L K\u00f6nig","year":"2020","unstructured":"K\u00f6nig L, Kalinichenko LS, Huber SE, Voll AM, Bauder M, Kornhuber J, et al. The selective FKBP51 inhibitor SAFit2 reduces alcohol consumption and reinstatement of conditioned alcohol effects in mice. Addict Biol. 2020. https:\/\/doi.org\/10.1111\/adb.12758.","journal-title":"Addict Biol"},{"key":"654_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01783-y","author":"G Balsevich","year":"2017","unstructured":"Balsevich G, H\u00e4usl AS, Meyer CW, Karamihalev S, Feng X, P\u00f6hlmann ML, et al. Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function. Nat Commun. 2017. https:\/\/doi.org\/10.1038\/s41467-017-01783-y.","journal-title":"Nat Commun"},{"key":"654_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2019.09.003","author":"AS H\u00e4usl","year":"2019","unstructured":"H\u00e4usl AS, Balsevich G, Gassen NC, Schmidt MV. Focus on FKBP51: a molecular link between stress and metabolic disorders. Mol Metab. 2019. https:\/\/doi.org\/10.1016\/j.molmet.2019.09.003.","journal-title":"Mol Metab"},{"key":"654_CR127","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzad014","author":"JA Lerma Romero","year":"2023","unstructured":"Lerma Romero JA, Meyners C, Rupp N, Hausch F, Kolmar H. A protein engineering approach toward understanding FKBP51 conformational dynamics and mechanisms of ligand binding. Protein Eng Des Sele. 2023. https:\/\/doi.org\/10.1093\/protein\/gzad014.","journal-title":"Protein Eng Des Sele"},{"key":"654_CR128","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202309706","author":"TM Geiger","year":"2024","unstructured":"Geiger TM, Walz M, Meyners C, Kuehn A, Dreizler JK, Sugiarto WO, et al. Discovery of a potent proteolysis targeting chimera enables targeting the scaffolding functions of FK506-binding protein 51 (FKBP51). Angew Chem Int Ed. 2024. https:\/\/doi.org\/10.1002\/anie.202309706.","journal-title":"Angew Chem Int Ed"},{"key":"654_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2018.00262","author":"ML P\u00f6hlmann","year":"2018","unstructured":"P\u00f6hlmann ML, H\u00e4usl AS, Harbich D, Balsevich G, Engelhardt C, Feng X, et al. Pharmacological modulation of the psychiatric risk factor FKBP51 alters efficiency of common antidepressant drugs. Front Behav Neurosci. 2018. https:\/\/doi.org\/10.3389\/fnbeh.2018.00262.","journal-title":"Front Behav Neurosci"},{"key":"654_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40040-3","author":"J Bordes","year":"2023","unstructured":"Bordes J, Miranda L, Reinhardt M, Narayan S, Hartmann J, Newman EL, et al. Automatically annotated motion tracking identifies a distinct social behavioral profile following chronic social defeat stress. Nat Commun. 2023. https:\/\/doi.org\/10.1038\/s41467-023-40040-3.","journal-title":"Nat Commun"},{"key":"654_CR131","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-014-0483-7","author":"D Landgraf","year":"2014","unstructured":"Landgraf D, McCarthy MJ, Welsh DK. Circadian clock and stress interactions in the molecular biology of psychiatric disorders. Curr Psychiatry Rep. 2014. https:\/\/doi.org\/10.1007\/s11920-014-0483-7.","journal-title":"Curr Psychiatry Rep"},{"key":"654_CR132","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-265686","author":"M Cuesta","year":"2015","unstructured":"Cuesta M, Cermakian N, Boivin DB. Glucocorticoids entrain molecular clock components in human peripheral cells. FASEB J. 2015. https:\/\/doi.org\/10.1096\/fj.14-265686.","journal-title":"FASEB J"},{"key":"654_CR133","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30815","author":"AR Neves","year":"2022","unstructured":"Neves AR, Albuquerque T, Quintela T, Costa D. Circadian rhythm and disease: relationship, new insights, and future perspectives. J Cell Physiol. 2022. https:\/\/doi.org\/10.1002\/jcp.30815.","journal-title":"J Cell Physiol"},{"key":"654_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.07.008","author":"A Bhatnagar","year":"2023","unstructured":"Bhatnagar A, Murray G, Ray S. Circadian biology to advance therapeutics for mood disorders. Trends Pharmacol Sci. 2023. https:\/\/doi.org\/10.1016\/j.tips.2023.07.008.","journal-title":"Trends Pharmacol Sci"},{"key":"654_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00037","author":"R Dumbell","year":"2016","unstructured":"Dumbell R, Matveeva O, Oster H. Circadian clocks, stress, and immunity. Front Endocrinol (Lausanne). 2016. https:\/\/doi.org\/10.3389\/fendo.2016.00037.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"654_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.02.1176","author":"R Orozco-Solis","year":"2017","unstructured":"Orozco-Solis R, Montellier E, Aguilar-Arnal L, Sato S, Vawter MP, Bunney BG, et al. A circadian genomic signature common to ketamine and sleep deprivation in the anterior cingulate cortex. Biol Psychiatry. 2017. https:\/\/doi.org\/10.1016\/j.biopsych.2017.02.1176.","journal-title":"Biol Psychiatry"},{"key":"654_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3387","author":"C Liston","year":"2013","unstructured":"Liston C, Cichon JM, Jeanneteau F, Jia Z, Chao MV, Gan WB. Circadian glucocorticoid oscillations promote learning-dependent synapse formation and maintenance. Nat Neurosci. 2013. https:\/\/doi.org\/10.1038\/nn.3387.","journal-title":"Nat Neurosci"},{"key":"654_CR138","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2019.1679391","author":"M Woelfer","year":"2020","unstructured":"Woelfer M, Li M, Colic L, Liebe T, Di X, Biswal B, et al. Ketamine-induced changes in plasma brain-derived neurotrophic factor (BDNF) levels are associated with the resting-state functional connectivity of the prefrontal cortex. World J Biol Psychiatry. 2020. https:\/\/doi.org\/10.1080\/15622975.2019.1679391.","journal-title":"World J Biol Psychiatry"},{"key":"654_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2020.04.003","author":"LA Averill","year":"2020","unstructured":"Averill LA, Fouda S, Murrough JW, Abdallah CG. Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: an abridged review of the clinical evidence. Adv Pharmacol. 2020. https:\/\/doi.org\/10.1016\/bs.apha.2020.04.003.","journal-title":"Adv Pharmacol"},{"key":"654_CR140","doi-asserted-by":"publisher","DOI":"10.1039\/d2na00229a","author":"S Nasra","year":"2022","unstructured":"Nasra S, Bhatia D, Kumar A. Recent advances in nanoparticle-based drug delivery systems for rheumatoid arthritis treatment. Nanoscale Adv. 2022. https:\/\/doi.org\/10.1039\/d2na00229a.","journal-title":"Nanoscale Adv"},{"key":"654_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091836","author":"F L\u00fchder","year":"2017","unstructured":"L\u00fchder F, Reichardt HM. Novel drug delivery systems tailored for improved administration of glucocorticoids. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18091836.","journal-title":"Int J Mol Sci"},{"key":"654_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.87","author":"J Hartmann","year":"2017","unstructured":"Hartmann J, Dedic N, P\u00f6hlmann ML, H\u00e4usl A, Karst H, Engelhardt C, et al. Forebrain glutamatergic, but not GABAergic, neurons mediate anxiogenic effects of the glucocorticoid receptor. Mol Psychiatry. 2017. https:\/\/doi.org\/10.1038\/mp.2016.87.","journal-title":"Mol Psychiatry"},{"key":"654_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0450-4","author":"U Skupio","year":"2020","unstructured":"Skupio U, Tertil M, Bilecki W, Barut J, Korostynski M, Golda S, et al. Astrocytes determine conditioned response to morphine via glucocorticoid receptor-dependent regulation of lactate release. Neuropsychopharmacology. 2020. https:\/\/doi.org\/10.1038\/s41386-019-0450-4.","journal-title":"Neuropsychopharmacology"},{"key":"654_CR144","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.14999","author":"V Nold","year":"2021","unstructured":"Nold V, Richter N, Hengerer B, Kolassa IT, Allers KA. FKBP5 polymorphisms induce differential glucocorticoid responsiveness in primary CNS cells\u2014first insights from novel humanized mice. Eur J Neurosci. 2021. https:\/\/doi.org\/10.1111\/ejn.14999.","journal-title":"Eur J Neurosci"},{"key":"654_CR145","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22460","author":"M Slezak","year":"2013","unstructured":"Slezak M, Korostynski M, Gieryk A, Golda S, Dzbek J, Piechota M, et al. Astrocytes are a neural target of morphine action via glucocorticoid receptor-dependent signaling. Glia. 2013. https:\/\/doi.org\/10.1002\/glia.22460.","journal-title":"Glia"},{"key":"654_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0300-x","author":"M Tertil","year":"2018","unstructured":"Tertil M, Skupio U, Barut J, Dubovyk V, Wawrzczak-Bargiela A, Soltys Z, et al. Glucocorticoid receptor signaling in astrocytes is required for aversive memory formation. Transl Psychiatry. 2018. https:\/\/doi.org\/10.1038\/s41398-018-0300-x.","journal-title":"Transl Psychiatry"},{"key":"654_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01708-2","author":"TA Dixon","year":"2023","unstructured":"Dixon TA, Muotri AR. Advancing preclinical models of psychiatric disorders with human brain organoid cultures. Mol Psychiatry. 2023. https:\/\/doi.org\/10.1038\/s41380-022-01708-2.","journal-title":"Mol Psychiatry"},{"key":"654_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2014.158","author":"MA Lancaster","year":"2014","unstructured":"Lancaster MA, Knoblich JA. Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc. 2014. https:\/\/doi.org\/10.1038\/nprot.2014.158.","journal-title":"Nat Protoc"},{"key":"654_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2012.02.024","author":"CH Bourke","year":"2012","unstructured":"Bourke CH, Harrell CS, Neigh GN. Stress-induced sex differences: adaptations mediated by the glucocorticoid receptor. Horm Behav. 2012. https:\/\/doi.org\/10.1016\/j.yhbeh.2012.02.024.","journal-title":"Horm Behav"},{"key":"654_CR150","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.113.115899","author":"S Petropoulos","year":"2014","unstructured":"Petropoulos S, Matthews SG, Szyf M. Adult glucocorticoid exposure leads to transcriptional and DNA methylation changes in nuclear steroid receptors in the hippocampus and kidney of mouse male offspring. Biol Reprod. 2014. https:\/\/doi.org\/10.1095\/biolreprod.113.115899.","journal-title":"Biol Reprod"},{"key":"654_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02350-2","author":"LB Hoffmann","year":"2024","unstructured":"Hoffmann LB, Li B, Zhao Q, Wei W, Leighton LJ, Bredy TW, et al. Chronically high stress hormone levels dysregulate sperm long noncoding RNAs and their embryonic microinjection alters development and affective behaviours. Mol Psychiatry. 2024. https:\/\/doi.org\/10.1038\/s41380-023-02350-2.","journal-title":"Mol Psychiatry"},{"key":"654_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02684-z","author":"V Fischer","year":"2023","unstructured":"Fischer V, Kretschmer M, Germain PL, Kaur J, Mompart-Barrenechea S, Pelczar P, et al. Sperm chromatin accessibility\u2019s involvement in the intergenerational effects of stress hormone receptor activation. Transl Psychiatry. 2023. https:\/\/doi.org\/10.1038\/s41398-023-02684-z.","journal-title":"Transl Psychiatry"},{"key":"654_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.109","author":"AK Short","year":"2016","unstructured":"Short AK, Fennell KA, Perreau VM, Fox A, Obryan MK, Kim JH, et al. Elevated paternal glucocorticoid exposure alters the small noncoding RNA profile in sperm and modifies anxiety and depressive phenotypes in the offspring. Transl Psychiatry. 2016. https:\/\/doi.org\/10.1038\/tp.2016.109.","journal-title":"Transl Psychiatry"},{"key":"654_CR154","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13803","author":"MD Hurtado","year":"2018","unstructured":"Hurtado MD, Cortes T, Natt N, Young WF, Bancos I. Extensive clinical experience: hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess. Clin Endocrinol (Oxf). 2018. https:\/\/doi.org\/10.1111\/cen.13803.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"654_CR155","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2020.2019.0220","author":"A G\u00fcven","year":"2020","unstructured":"G\u00fcven A. Different potent glucocorticoids, different routes of exposure but the same result: Iatrogenic cushing\u2019s syndrome and adrenal insufficiency. J Clin Res Pediatr Endocrinol. 2020. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2020.2019.0220.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"654_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2020.02.006","author":"M Kostic","year":"2020","unstructured":"Kostic M, Jones LH. Critical assessment of targeted protein degradation as a research tool and pharmacological modality. Trends Pharmacol Sci. 2020. https:\/\/doi.org\/10.1016\/j.tips.2020.02.006.","journal-title":"Trends Pharmacol Sci"},{"key":"654_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.11.031","author":"GM Burslem","year":"2020","unstructured":"Burslem GM, Crews CM. Proteolysis-targeting chimeras as therapeutics and tools for biological discovery. Cell. 2020. https:\/\/doi.org\/10.1016\/j.cell.2019.11.031.","journal-title":"Cell"},{"key":"654_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2011.12.004","author":"AR Clark","year":"2012","unstructured":"Clark AR, Belvisi MG. Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor. Pharmacol Ther. 2012. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.12.004.","journal-title":"Pharmacol Ther"},{"key":"654_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(02)00297-8","author":"H Sch\u00e4cke","year":"2002","unstructured":"Sch\u00e4cke H, D\u00f6cke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002. https:\/\/doi.org\/10.1016\/S0163-7258(02)00297-8.","journal-title":"Pharmacol Ther"},{"key":"654_CR160","doi-asserted-by":"publisher","DOI":"10.1177\/1359786806066063","author":"CM Pariante","year":"2006","unstructured":"Pariante CM. The glucocorticoid receptor: part of the solution or part of the problem? J Psychopharmacol. 2006. https:\/\/doi.org\/10.1177\/1359786806066063.","journal-title":"J Psychopharmacol"},{"key":"654_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001032","author":"PW Gold","year":"2002","unstructured":"Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH\/NE states. Mol Psychiatry. 2002. https:\/\/doi.org\/10.1038\/sj.mp.4001032.","journal-title":"Mol Psychiatry"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00654-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-024-00654-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00654-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T01:03:25Z","timestamp":1732151005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-024-00654-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":161,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["654"],"URL":"https:\/\/doi.org\/10.1007\/s43440-024-00654-w","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}